BioAge Labs, Inc. (BIOA)

BioAge Labs Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	215.57	354.35	21.64	27.64
Cash & Short-Term Investments	285.78	354.35	21.64	27.64
Cash Growth	-14.56%	1537.17%	-21.70%	-
Prepaid Expenses	4.54	2.75	0.35	0.39
Restricted Cash	-	-	3.31	-
Total Current Assets	290.83	357.1	25.31	28.03
Property, Plant & Equipment	3.86	0.79	0.52	0.37
Long-Term Investments	10.18	0.1	0.1	-
Other Long-Term Assets	0.23	0.24	-	0.03
Total Assets	305.09	358.23	25.92	28.43
Accounts Payable	5.02	2	1.87	2.26
Accrued Expenses	6.37	11.33	6.55	3.36
Short-Term Debt	-	-	38.86	-
Current Portion of Long-Term Debt	4.13	6	6	0.17
Current Portion of Leases	0.58	0.2	0.19	0.05
Current Unearned Revenue	7.51	7.83	3.31	-
Other Current Liabilities	0.89	0.42	1.39	0.02
Total Current Liabilities	24.49	27.78	58.17	5.86
Long-Term Debt	-	2.5	8.2	2.25
Long-Term Unearned Revenue	0.56	4.67	-	-
Other Long-Term Liabilities	0.15	0.16	0.23	0.15
Total Liabilities	27.63	35.11	66.6	8.27
Additional Paid-In Capital	584.66	575.69	8.14	5.12
Retained Earnings	-307.47	-252.81	-181.7	-117.85
Comprehensive Income & Other	0.28	0.25	0.16	0.17
Total Common Equity	277.46	323.13	-173.4	-112.56
Shareholders' Equity	277.46	323.13	-40.67	20.16
Total Liabilities & Equity	305.09	358.23	25.92	28.43
Total Debt	7.13	8.7	53.25	2.47
Net Cash (Debt)	288.72	345.65	-31.61	25.18
Net Cash Per Share	8.04	32.22	-18.90	15.06
Filing Date Shares Outstanding	35.86	35.85	1.67	1.67
Total Common Shares Outstanding	35.85	35.85	1.67	1.67
Working Capital	266.34	329.33	-32.86	22.17
Book Value Per Share	7.74	9.01	-103.62	-67.33
Tangible Book Value	277.46	323.13	-173.4	-112.56
Tangible Book Value Per Share	7.74	9.01	-103.62	-67.33
Machinery	1.21	0.79	0.74	0.58
Construction In Progress	0.02	0.18	-	-

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q